NO20070373L - Aerosol suspensjonsformulering inneholdende TG 227 EA eller TG 134 A som et drivmiddel - Google Patents

Aerosol suspensjonsformulering inneholdende TG 227 EA eller TG 134 A som et drivmiddel

Info

Publication number
NO20070373L
NO20070373L NO20070373A NO20070373A NO20070373L NO 20070373 L NO20070373 L NO 20070373L NO 20070373 A NO20070373 A NO 20070373A NO 20070373 A NO20070373 A NO 20070373A NO 20070373 L NO20070373 L NO 20070373L
Authority
NO
Norway
Prior art keywords
propellant
formulation containing
suspension formulation
aerosol suspension
water
Prior art date
Application number
NO20070373A
Other languages
English (en)
Norwegian (no)
Inventor
Christel Schmelzer
Arne Froemder
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35169696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20070373(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102004032322A external-priority patent/DE102004032322A1/de
Priority claimed from DE200510023334 external-priority patent/DE102005023334A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20070373L publication Critical patent/NO20070373L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20070373A 2004-07-02 2007-01-19 Aerosol suspensjonsformulering inneholdende TG 227 EA eller TG 134 A som et drivmiddel NO20070373L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004032322A DE102004032322A1 (de) 2004-07-02 2004-07-02 Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
DE200510023334 DE102005023334A1 (de) 2005-05-17 2005-05-17 Aeorosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
PCT/EP2005/006865 WO2006002840A2 (fr) 2004-07-02 2005-06-25 Formulations de suspensions aerosol contenant tg 227 ea ou tg 134 a en tant qu'agent propulseur

Publications (1)

Publication Number Publication Date
NO20070373L true NO20070373L (no) 2007-01-31

Family

ID=35169696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070373A NO20070373L (no) 2004-07-02 2007-01-19 Aerosol suspensjonsformulering inneholdende TG 227 EA eller TG 134 A som et drivmiddel

Country Status (19)

Country Link
US (1) US8357352B2 (fr)
EP (1) EP1809243B2 (fr)
JP (1) JP5209963B2 (fr)
KR (1) KR101297061B1 (fr)
AR (1) AR049660A1 (fr)
AU (1) AU2005259523B2 (fr)
BR (1) BRPI0512878A (fr)
CA (1) CA2571519C (fr)
DK (1) DK1809243T4 (fr)
EA (1) EA013428B1 (fr)
EC (1) ECSP077126A (fr)
ES (1) ES2391563T5 (fr)
IL (1) IL180461A0 (fr)
MX (1) MXPA06015204A (fr)
NO (1) NO20070373L (fr)
NZ (1) NZ552869A (fr)
PL (1) PL1809243T5 (fr)
TW (1) TWI377943B (fr)
WO (1) WO2006002840A2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1809243T5 (pl) 2004-07-02 2022-12-27 Boehringer Ingelheim International Gmbh Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
WO2008047239A2 (fr) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Formulatons pharmaceutiques en aérosol stables
GB2442745B (en) * 2006-10-13 2011-04-06 At & T Corp Method and apparatus for acoustic sensing using multiple optical pulses
GB2442746B (en) * 2006-10-13 2011-04-06 At & T Corp Method and apparatus for acoustic sensing using multiple optical pulses
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
BRPI1007885A2 (pt) * 2009-02-03 2016-02-16 Microbion Corp bismuto-tóis antissépticos para tecidos epiteliais, feridas agudas e crônicas, biofilmes bacterianos e outras indicações
EP2414560B1 (fr) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Procédé de revêtement d'une surface d'un composant
WO2010133294A2 (fr) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapteur, dispositif d'inhalation et nébuliseur
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
CN102686260B (zh) 2009-11-25 2014-10-01 贝林格尔.英格海姆国际有限公司 喷雾器
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (fr) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
UA121114C2 (uk) 2014-05-07 2020-04-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх Небулайзер, індикаторний пристрій і контейнер
EP3139979B1 (fr) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unité, nébuliseur et procédé
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador
US10322198B2 (en) 2016-07-08 2019-06-18 The Procter & Gamble Company Freshening compositions comprising isopropyl myristate

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8824804D0 (en) 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5919435A (en) 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
SK280911B6 (sk) * 1992-12-09 2000-09-12 Boehringer Ingelheim Pharmaceuticals, Inc. Farmaceutický prostriedok
ES2109696T3 (es) 1993-04-30 1998-01-16 Minnesota Mining & Mfg Configuracion de cierre hermetico para botes de aerosol.
WO1995002651A1 (fr) 1993-07-15 1995-01-26 Minnesota Mining And Manufacturing Company Diaphragmes d'etancheite destine a un dispositif de vaporisation d'aerosol
NZ306281A (en) 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler with part or all internal surfaces coated with fluorocarbon polymers for dispensing beclomethasone dipropionate
GB9513084D0 (en) 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
JP3801348B2 (ja) 1997-07-28 2006-07-26 株式会社ヴァレオサーマルシステムズ レシーバタンク
JP4117059B2 (ja) * 1998-02-10 2008-07-09 東洋エアゾール工業株式会社 高濃度粉末エアゾール製品
US6423298B2 (en) 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
PT1102579E (pt) 1998-08-04 2003-07-31 Jago Res Ag Formulacoes de aerossol medicinais
US5955958A (en) † 1998-10-05 1999-09-21 Lu; Kai Holiday candy jar with light and sound effects
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6261539B1 (en) 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US6739333B1 (en) * 1999-05-26 2004-05-25 Boehringer Ingelheim Pharma Kg Stainless steel canister for propellant-driven metering aerosols
GB0002798D0 (en) 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
WO2002005785A1 (fr) * 2000-07-18 2002-01-24 Aeropharm Technology Incorporated Aerosols therapeutiques a liberation modulee
AU2001278115A1 (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
DE10043509A1 (de) 2000-09-01 2002-03-14 Asta Medica Ag Feste Peptidzubereitungen für die Inhalation und deren Herstellung
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
EP1241113A1 (fr) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhalateur avec des moyens pour améliorer la stabilité chimique des solutions d'aerosol médicinales qu'il contient
DK1414508T3 (da) 2001-06-26 2011-08-08 Norton Healthcare Ltd Forbedret reguleringsorgan til aerosoler
BR0307235A (pt) 2002-02-01 2004-12-07 Atrazeneca Ab Composição para inalação
EP1340492A1 (fr) 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formulations d'aérosol pour l'administration par voie pulmonaire de medicaments avec effet systémique
ATE465712T1 (de) 2002-03-01 2010-05-15 Chiesi Farma Spa Ultrafeine zusammensetzungen von formoterol
DE10214263A1 (de) † 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
AU2003287500B2 (en) 2002-11-22 2009-11-19 Eli Lilly And Company Vitamin D receptor modulators
EA009087B1 (ru) * 2003-03-20 2007-10-26 Бёрингер Ингельхайм Фармасьютиклз, Инк. Состав для ингалятора, выдающего мерную дозу препарата, с использованием гидрофторалканов в качестве пропеллентов
AR041873A1 (es) † 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
DE102004032322A1 (de) 2004-07-02 2006-02-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
PL1809243T5 (pl) 2004-07-02 2022-12-27 Boehringer Ingelheim International Gmbh Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy
NZ555500A (en) 2004-12-17 2010-09-30 Cipla Ltd Crystalline forms of levosalbutamol sulfate, process for their preparation, and their use in respiratory conditions
DE102006053374A1 (de) 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel

Also Published As

Publication number Publication date
WO2006002840A8 (fr) 2012-11-08
PL1809243T5 (pl) 2022-12-27
BRPI0512878A (pt) 2008-04-15
US20060002863A1 (en) 2006-01-05
EP1809243B2 (fr) 2022-06-08
IL180461A0 (en) 2007-06-03
ES2391563T5 (es) 2022-10-26
JP2008504325A (ja) 2008-02-14
MXPA06015204A (es) 2007-03-15
AU2005259523B2 (en) 2011-06-09
DK1809243T3 (da) 2012-10-15
AU2005259523A1 (en) 2006-01-12
EA200700042A1 (ru) 2007-08-31
ES2391563T3 (es) 2012-11-27
DK1809243T4 (da) 2022-09-05
EP1809243B1 (fr) 2012-07-18
JP5209963B2 (ja) 2013-06-12
NZ552869A (en) 2010-06-25
TWI377943B (en) 2012-12-01
CA2571519C (fr) 2013-05-14
US8357352B2 (en) 2013-01-22
PL1809243T3 (pl) 2013-05-31
CA2571519A1 (fr) 2006-01-12
WO2006002840A2 (fr) 2006-01-12
EP1809243A2 (fr) 2007-07-25
AR049660A1 (es) 2006-08-23
WO2006002840A3 (fr) 2006-11-16
EA013428B1 (ru) 2010-04-30
TW200612945A (en) 2006-05-01
ECSP077126A (es) 2007-02-28
KR20070042166A (ko) 2007-04-20
EP1809243B8 (fr) 2013-02-27
KR101297061B1 (ko) 2013-08-19

Similar Documents

Publication Publication Date Title
NO20070373L (no) Aerosol suspensjonsformulering inneholdende TG 227 EA eller TG 134 A som et drivmiddel
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
NO20052493D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
MXPA03010640A (es) Composiciones pesticidas liquidas estables.
NO20043353L (no) Antistoff-inneholdende opplosningsfarmasoytika
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
SE9904652D0 (sv) Novel Compounds
NO20052995D0 (no) 1,5-diaryl-pyrrol-3-karboksamid-derivater, og deres anvendelse som kannabinoid reseptormodulatorer.
RS53895B1 (en) ATP-BINDING CASSETTE TRANSPORT MODULATORS
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
UY28348A1 (es) Compuestos novedosos
WO2004110352A3 (fr) Composes accroissant le transport d'ions par des cftr de mutants, et leurs utilisations
NO20042635L (no) 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
DK1814848T3 (da) 2,3,4-substitueret-cyclopentanoner som terapeutiske midler
EP1930520A3 (fr) Construction en treillis modulaire en béton
NO20073026L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav
NO20054535L (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
DK1575948T3 (da) Pyridodiaziner som plantefungicider
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
ATE404602T1 (de) Wässrige polyurethanzubereitungen
CU23309B7 (es) Compuestos anã logos de astrobilurinas y su uso como acaricida e insecticida
NO20053598D0 (no) Substituerte 1-piperidin-3-yl-4-pyrrolidin-4-yl-piperazinderivater og deres anvendelse som nevrokininantagonister.